Market cap
$612.027 M
$0.95 -12.04%
Close of 6 Nov 2026
As of 6 Nov 2026, Geron (GERN) has a market capitalization of $612.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$83.5M
Loss-making
Shares outstanding
644,238,859
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #172Adlai Nortye GroupANL$619.5M
- #173Helus PharmaHELP$613.7M
- #174GeronGERN$612.0M
- #175Nuvectis PharmaNVCT$610.7M
- #176Kura OncologyKURA$606.3M
What if Geron were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Geron are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.